Timing of antibiotics in the management of community-acquired sepsis: Can a randomised controlled trial of prehospital therapy provide answers?
Andrew A UdyKaren SmithStephen BernardPublished in: Emergency medicine Australasia : EMA (2017)
Significant tension surrounds the application of antibiotics in suspected infection. Guidelines stress the importance of early empirical broad-spectrum therapy, with select observational data suggesting inferior outcomes when this is delayed. In contrast, microbiological resistance is an ever increasing global problem, with many advocating for a more restricted, culture-driven approach to antibiotic prescription. Controlled trial data are urgently needed, although many clinicians would find withholding of antibiotic therapy unethical. A trial of prehospital antibiotic administration (by paramedics) in patients with suspected sepsis would therefore provide crucial data, and go a long way to determining whether earlier empirical therapy does actually improve outcomes.
Keyphrases
- electronic health record
- intensive care unit
- healthcare
- acute kidney injury
- clinical trial
- big data
- magnetic resonance
- stem cells
- randomized controlled trial
- mental health
- pulmonary embolism
- metabolic syndrome
- mesenchymal stem cells
- insulin resistance
- cross sectional
- artificial intelligence
- septic shock
- double blind
- replacement therapy
- stress induced
- contrast enhanced